TOP STORIES
Novartis has now launched “Novartis Access” – which will be a portfolio of affordable medicines used to treat diseases in low-income countries. — Novartis
GE Healthcare will take a “startup approach” in its new $300 million emerging markets fund. – MassDevice
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
Your mandatory Martin Shkreli fix:
- Turing Pharmaceuticals has been kicked out of BIO. “The company and its leadership do not reflect the commitment to innovation and values that are at the core of BIO’s reputation and mission.” – FierceBiotech
- Shkreli’s done. But biotech has to clean up the mess. – FierceBiotech
- Republicans will warm to drug-pricing reform in five to 10 years. – Xconomy
- Donald Trump: “I thought it was disgusting what he did.” – The Hill
Penumbra hits its IPO mark, clears $125 million in its IPO. – MassDevice
Israeli medical device company ElastiMed has raised $1 million. It is developing a new device to treat Chronic Venous Insufficiency and prevent Deep Venous Thrombosis. – PRNewswire
Stemina Biomarker Discovery has launched a 1,500-patient study of its experimental test to diagnose children with autism spectrum disorder. – Xconomy
The FDA published a warning letter it sent to NSC Pearson over issues with the company’s Quotient ADHD being marketed as a consumer device to treat ADHD without the proper clearance. — MassDevice
PAYERS-PROVIDERS
Hospital CEOs sometimes call it quits unexpectedly – here are some reasons why. — Becker’s Hospital Review
Patient safety experts say the Institute of Medicine’s new report on reducing diagnostic errors, “Improving Diagnosis in Health Care,” is a “major milestone” in the effort to improve diagnoses, save lives and advance care. — Fierce Healthcare
TECH
An entertaining exchange between TechCrunch and Vinod Khosla at Disrupt: “Because you writers like headlines, I’ll repeat the headlines from last year. I don’t think 90% of VCs add any value. 70% of them actually add negative value that gets tweeted a lot, so it’s good for media.” – Business Insider
The FTC fined Carrot Neurotechnology $150,000 for its Ultimeyes mobile app that claims to improve users’ eyesight without scientific evidence to support those claims. The “scientific research” was written by one of the company owners. — HealthcareDive
A researcher at Florida Atlantic University has received a $166,935 grant from the National Science Foundation to develop a smartphone-connected test to be used by people with sickle cell disease. — Mobihealthnews
POLITICS
Hillary Clinton is promising to “build on” Obamac are with new proposals that would crack down on insurers to limit premium hikes and halt rising out-of-pocket healthcare costs. — The Hill
A LITTLE BIT EXTRA
A toilet college is set to open in India. That’s right. A toilet college. The effort is designed to increase sanitation and education in the country – one in which people reportedly have more access to cellphones than toilets. — Forbes
Photo: Novartis headquarters from Flickr user Michael Layefsky